340B PATIENTS Act of 2025

# Summary of the 340B PATIENTS Act of 2025 **What the Bill Does** This bill would modify the 340B drug pricing program, a federal program that requires pharmaceutical manufacturers to offer discounted drugs to certain hospitals and healthcare providers. The bill appears designed to protect or expand patient access to these discounted medications, though specific provisions aren't detailed in the available information. **Who It Affects** The bill would impact pharmaceutical companies, hospitals, safety-net healthcare providers (like those serving uninsured or low-income patients), and ultimately patients who rely on discounted medications. The 340B program primarily benefits community health centers, hospitals treating vulnerable populations, and certain other qualifying healthcare entities. **Current Status** The bill was introduced by Senator Peter Welch (D-Vermont) and is currently in committee review.

This means it hasn't yet been debated or voted on by the full Senate. Many bills introduced in Congress never advance beyond the committee stage. **Note:** Complete details about specific provisions weren't available in the source information provided. To learn exactly what changes this bill proposes to the 340B program, you could check Congress.gov or the bill's full text for more comprehensive information.